04/16/2025
On October 31, 2024, Cartiva, Inc. issued an urgent FDA Class II Device Recall of the Cartiva Synthetic Cartilage Toe Implant sold from July 2016 to October 2024. The FDA Recall was necessary due to a higher-than-expected rate of serious injuries including pain, nerve damage, implant subsidence and fragmentation, and the need for revision or toe fusion surgery. Patients who have been implanted with the Cartiva Synthetic Cartilage Toe Implant may have a claim for injuries including pain and suffering, medical expenses, lost wages, and other damages. Our firm has over 20 years’ experience handling complex medical device injury cases. For a confidential claim evaluation, send us a message below or contact our Portland, Maine office at (207) 874-7407 or [email protected].